|
PURE Pure Bioscience Inc 1006028 |
| Income Statement |
|
Revenue
|
form10-q
|
556,000 |
|
Net Income
|
form10-q
|
-689,000 |
|
Profit Margin
|
|
-123.92% |
| Balance Sheet |
|
Current Assets
|
911,000 |
|
Assets
|
924,000 |
|
Current Liabilities
|
911,000 |
|
Liabilities
|
4,420,000 |
|
Equity
|
-3,496,000 |
|
Shares Out
|
111,856,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-503,000 |
| Market Analysis |
Market Cap
|
6,957,474 |
|
Price
|
0.07 |
|
BVPS
|
0.02 |
|
PB
|
2.96 |
|
EPS
|
-0.03 |
|
PS
|
3.13 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view PURE documents filed with the SEC.
PURE Filings
Clear
